Your browser doesn't support javascript.
loading
Clascoterone for treatment of acne.
Manjaly, Cyriac; Martinez, Jeremy; Barbieri, John; Mostaghimi, Arash.
Afiliação
  • Manjaly C; Vanderbilt University, College of Arts and Science, Nashville, Tennessee, USA.
  • Martinez J; Harvard Medical School, Department of Dermatology, Boston, Massachusetts, USA.
  • Barbieri J; Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Mostaghimi A; Brigham and Women's Hospital, Boston, Massachusetts, USA. amostaghimi@bwh.harvard.edu.
Drugs Today (Barc) ; 59(2): 71-81, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36811407
ABSTRACT
Clascoterone is a novel topical antiandrogen medication approved for the treatment of acne. Conventional oral antiandrogen treatments targeting acne such as combined oral contraceptives and spironolactone exert systemic hormonal effects which commonly preclude their usage in male patients while hampering their application in certain female patients. In contrast, clascoterone is a first-in-class antiandrogen proven to be both safe and effective for female and male patients above the age of 12. Outside of occasional localized skin irritation, clascoterone is usually well tolerated, however, some adolescents in a phase II clinical trial experienced biochemical evidence of HPA suppression, which resolved after discontinuing treatment. In this review, we provide an overview of clascoterone including its preclinical pharmacology, pharmacokinetics and metabolism, safety, clinical studies and indications.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acne Vulgar Limite: Adolescent / Female / Humans / Male Idioma: En Revista: Drugs Today (Barc) Assunto da revista: MEDICINA OCUPACIONAL / SAUDE AMBIENTAL Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acne Vulgar Limite: Adolescent / Female / Humans / Male Idioma: En Revista: Drugs Today (Barc) Assunto da revista: MEDICINA OCUPACIONAL / SAUDE AMBIENTAL Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos